Skip to main content
Journal cover image

SURVIVAL AND TOXICITY UPDATE OF THE PHASE 2 TRIAL OF BEVACIZUMAB (BV) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) PATIENTS

Publication ,  Conference
Desjardins, A; Reardon, DA; Peters, KB; Herndon, JE; Kirkpatrick, JP; Friedman, HS; Vredenburgh, JJ
Published in: NEURO-ONCOLOGY
November 1, 2010

Duke Scholars

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

November 1, 2010

Volume

12

Start / End Page

77 / 77

Location

Hollywood, FL

Publisher

OXFORD UNIV PRESS INC

Conference Name

Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Reardon, D. A., Peters, K. B., Herndon, J. E., Kirkpatrick, J. P., Friedman, H. S., & Vredenburgh, J. J. (2010). SURVIVAL AND TOXICITY UPDATE OF THE PHASE 2 TRIAL OF BEVACIZUMAB (BV) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) PATIENTS. In NEURO-ONCOLOGY (Vol. 12, pp. 77–77). Hollywood, FL: OXFORD UNIV PRESS INC.
Desjardins, Annick, David A. Reardon, Katherine B. Peters, James E. Herndon, John P. Kirkpatrick, Henry S. Friedman, and James J. Vredenburgh. “SURVIVAL AND TOXICITY UPDATE OF THE PHASE 2 TRIAL OF BEVACIZUMAB (BV) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) PATIENTS.” In NEURO-ONCOLOGY, 12:77–77. OXFORD UNIV PRESS INC, 2010.
Journal cover image

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

November 1, 2010

Volume

12

Start / End Page

77 / 77

Location

Hollywood, FL

Publisher

OXFORD UNIV PRESS INC

Conference Name

Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences